Baxter 2021 Corporate Responsibility Report 53 Appendix 2030 Corporate Responsibility Goals Corporate Responsibility Commitment Empower Our Patients Protect Our Planet Champion Our People and Communities Introduction Cross-Cutting Commitments Appendix: Materiality Assessment Findings 1 For more information about the process we undertook and the key findings of our 2018 assessment, see page 6 of our 2018 Corporate Responsibility Report . Climate Change Reducing energy consumption and expanding use of renewable energy in Baxter’s operations and reducing greenhouse gas emissions across our value chain; incorporating climate change strategy, including adaptation and resilience planning, into relevant business decisions. Learn more. Community Support and Volunteerism Supporting communities in need where Baxter has a presence, with partnerships aimed at addressing economic, environmental and social needs, including through financial contributions and employee volunteerism. Learn more. Diversity and Inclusion Maintaining an inclusive, nondiscriminatory hiring process and culture; providing employees equal pay for equal work regardless of gender, race, sexual orientation or disability; welcoming, leveraging and appreciating the uniqueness of every Baxter employee; and supporting supplier diversity. Learn more. Employee Attraction, Development and Retention Attracting, engaging and retaining top talent by providing employees career and personal training and development opportunities, and designing succession plans to ensure there are qualified Baxter candidates for critical positions; upholding labor rights and ensuring that labor concerns can be reported. Learn more. Ethics and Compliance Providing an effective corporate governance structure, business processes, marketing standards, and reporting mechanisms, and fostering an open culture that demonstrates the highest ethics and anticorruption standards. Learn more. Health, Safety and Well-Being Providing employees with a zero-harm workplace, an environment that encourages healthy choices, and resources to maintain and improve their health and safety and that of their families. Learn more. Healthcare Access and Affordability Improving access to, and affordability of, Baxter products and services for populations in need through product innovation, public health initiatives, public policy efforts, business model innovation and strategic giving, which includes product donations and grants from the Baxter International Foundation. Learn more. Human Rights Ensuring workers across Baxter’s value chain are treated in accordance with international standards of human rights. Learn more. Innovation Investing in innovation that solves for unmet needs and improves patient outcomes and standards of care. Learn more. Patient Safety and Quality Helping to ensure quality and patient safety across the product life cycle through leading practices in design, materials use, manufacturing, communications, surveillance and reporting. Learn more. Privacy and Data Protection Protecting personal information from unauthorized or inappropriate collection, processing and disclosure, and protecting information resources from threats, whether internal or external, deliberate or accidental. Learn more. Product Sustainability Incorporating and managing sustainability across the product life cycle (R&D and design, materials use including chemicals of concern, manufacturing, product transport, packaging, product use and end-of-life), and communicating sustainable product attributes to customers. Learn more. Supply Chain Sustainability Working with suppliers to improve their own sustainability programs and performance, as well as Baxter’s. Learn more. Waste Minimizing disposal of manufacturing waste from Baxter’s operations, first through source reduction and reuse and then through recycling and energy recovery. Learn more. Water Use Reducing water use in Baxter’s operations, increasing reuse, managing water discharge quality and protecting local water sources, especially in water-scarce areas. Learn more. ISSUE DESCRIPTION Upstream Downstream Baxter Operations IMPACT WITHIN VALUE CHAIN